| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | May 14, 2024 | Option Exercise | $42.76 | 12,500 | 534,500 | 129,447 | May 16, 2024, 04:55 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | May 14, 2024 | Sale | $135.63 | 12,500 | 1,695,370 | 116,947 | May 16, 2024, 04:55 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 15, 2024 | Sale | $140.24 | 15,000 | 2,103,609 | 31,528 | May 16, 2024, 04:40 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 14, 2024 | Option Exercise | $73.60 | 15,000 | 1,104,000 | 46,528 | May 16, 2024, 04:40 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 14, 2024 | Sale | $135.66 | 15,000 | 2,034,827 | 31,528 | May 16, 2024, 04:40 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 15, 2024 | Option Exercise | $73.60 | 15,000 | 1,104,000 | 46,528 | May 16, 2024, 04:40 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | May 06, 2024 | Option Exercise | $79.02 | 273 | 21,572 | 7,780 | May 08, 2024, 04:26 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | May 06, 2024 | Sale | $140.55 | 273 | 38,370 | 7,507 | May 08, 2024, 04:26 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Apr 15, 2024 | Sale | $133.36 | 19,818 | 2,643,020 | 40,778 | Apr 17, 2024, 05:19 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Apr 15, 2024 | Option Exercise | $81.21 | 19,818 | 1,609,431 | 53,365 | Apr 17, 2024, 05:19 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Mar 21, 2024 | Option Exercise | $103.52 | 5,000 | 517,600 | 12,507 | Mar 25, 2024, 06:02 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Mar 21, 2024 | Sale | $145.06 | 5,000 | 725,320 | 7,507 | Mar 25, 2024, 06:02 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Mar 14, 2024 | Option Exercise | $80.90 | 75,000 | 6,067,628 | 110,299 | Mar 15, 2024, 05:33 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Mar 14, 2024 | Sale | $139.38 | 75,000 | 10,453,418 | 40,778 | Mar 15, 2024, 05:33 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | MORROW GEORGE J | Director | Mar 14, 2024 | Option Exercise | $39.79 | 40,000 | 1,591,600 | 20,000 | Mar 15, 2024, 05:25 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | MORROW GEORGE J | Director | Mar 14, 2024 | Sale | $139.42 | 40,000 | 5,576,710 | 0 | Mar 15, 2024, 05:25 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | Mar 13, 2024 | Sale | $140.33 | 23,200 | 3,255,621 | 29,512 | Mar 15, 2024, 05:19 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | Mar 13, 2024 | Option Exercise | $42.76 | 23,200 | 992,032 | 52,712 | Mar 15, 2024, 05:19 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Mar 13, 2024 | Option Exercise | $106.02 | 3,000 | 318,060 | 10,507 | Mar 15, 2024, 05:15 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Mar 13, 2024 | Sale | $140.14 | 3,000 | 420,419 | 7,507 | Mar 15, 2024, 05:15 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | Mar 08, 2024 | Option Exercise | $42.76 | 1,700 | 72,692 | 31,212 | Mar 12, 2024, 06:47 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | Mar 08, 2024 | Sale | $140.05 | 1,700 | 238,078 | 29,512 | Mar 12, 2024, 06:47 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | Mar 11, 2024 | Option Exercise | $42.76 | 100 | 4,276 | 29,612 | Mar 12, 2024, 06:47 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | Mar 11, 2024 | Sale | $140.00 | 100 | 14,000 | 29,512 | Mar 12, 2024, 06:47 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Mar 11, 2024 | Sale | $140.00 | 200 | 28,000 | 7,507 | Mar 12, 2024, 06:38 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Mar 08, 2024 | Option Exercise | $106.02 | 1,800 | 190,836 | 9,307 | Mar 12, 2024, 06:38 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Mar 08, 2024 | Sale | $140.03 | 1,800 | 252,053 | 7,507 | Mar 12, 2024, 06:38 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Mar 11, 2024 | Option Exercise | $106.02 | 200 | 21,204 | 7,707 | Mar 12, 2024, 06:38 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Feb 29, 2024 | Option Exercise | $79.02 | 273 | 21,572 | 7,780 | Feb 29, 2024, 07:02 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Feb 29, 2024 | Sale | $135.51 | 273 | 36,994 | 7,507 | Feb 29, 2024, 07:02 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Feb 28, 2024 | Option Exercise | $79.02 | 6,544 | 517,107 | 10,007 | Feb 29, 2024, 07:02 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Feb 28, 2024 | Sale | $135.34 | 6,544 | 885,637 | 7,507 | Feb 29, 2024, 07:02 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Feb 28, 2024 | Option Exercise | $53.67 | 75,000 | 4,025,043 | 93,759 | Feb 29, 2024, 06:55 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Feb 28, 2024 | Sale | $134.69 | 75,000 | 10,101,607 | 40,616 | Feb 29, 2024, 06:55 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Director | Feb 27, 2024 | Sale | $135.67 | 8,000 | 1,085,388 | 0 | Feb 29, 2024, 06:50 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Director | Feb 27, 2024 | Option Exercise | $84.95 | 8,000 | 679,600 | 8,000 | Feb 29, 2024, 06:50 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | Feb 20, 2024 | Option Exercise | $12.98 | 15,000 | 194,700 | 44,512 | Feb 22, 2024, 05:11 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | Feb 20, 2024 | Sale | $132.47 | 15,000 | 1,987,047 | 29,512 | Feb 22, 2024, 05:11 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Feb 13, 2024 | Sale | $132.96 | 1,114 | 148,122 | 23,716 | Feb 15, 2024, 05:51 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | Chief Scientific Officer | Feb 13, 2024 | Sale | $132.94 | 1,432 | 190,371 | 13,128 | Feb 15, 2024, 05:48 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | Chief Legal Officer | Feb 13, 2024 | Sale | $132.99 | 1,098 | 146,028 | 39,740 | Feb 15, 2024, 05:45 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 13, 2024 | Sale | $133.02 | 2,832 | 376,700 | 514,596 | Feb 15, 2024, 05:43 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Business Development Off | Feb 13, 2024 | Sale | $132.89 | 1,352 | 179,674 | 135,166 | Feb 15, 2024, 05:40 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Feb 13, 2024 | Sale | $133.03 | 716 | 95,253 | 7,507 | Feb 15, 2024, 05:38 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Cooke Julie | Chief Human Resources Officer | Feb 13, 2024 | Sale | $133.04 | 796 | 105,902 | 17,976 | Feb 15, 2024, 05:35 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Boyer David W. | Chief Corp. Affairs Officer | Feb 13, 2024 | Sale | $133.07 | 1,811 | 240,996 | 5,751 | Feb 15, 2024, 05:33 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Feb 13, 2024 | Sale | $133.01 | 1,098 | 146,050 | 40,616 | Feb 15, 2024, 05:29 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 13, 2024 | Sale | $132.85 | 1,352 | 179,612 | 31,528 | Feb 15, 2024, 05:27 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 13, 2024 | Option Exercise | $39.28 | 5,090 | 199,951 | 512,052 | Feb 14, 2024, 05:17 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Boyer David W. | Chief Corp. Affairs Officer | Feb 06, 2024 | Sale | $141.96 | 456 | 64,734 | 5,110 | Feb 08, 2024, 07:46 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Boyer David W. | Chief Corp. Affairs Officer | Feb 08, 2024 | Sale | $135.41 | 1,328 | 179,830 | 5,523 | Feb 08, 2024, 07:46 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Cooke Julie | Chief Human Resources Officer | Feb 06, 2024 | Sale | $142.07 | 1,215 | 172,617 | 17,838 | Feb 08, 2024, 07:35 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Cooke Julie | Chief Human Resources Officer | Feb 08, 2024 | Sale | $135.44 | 1,329 | 179,995 | 17,892 | Feb 08, 2024, 07:35 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Feb 06, 2024 | Sale | $142.24 | 1,121 | 159,446 | 21,837 | Feb 08, 2024, 07:28 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Feb 08, 2024 | Sale | $134.21 | 980 | 131,522 | 22,717 | Feb 08, 2024, 07:28 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | Chief Legal Officer | Feb 08, 2024 | Sale | $134.24 | 911 | 122,289 | 38,755 | Feb 08, 2024, 07:25 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | Chief Legal Officer | Feb 06, 2024 | Sale | $142.17 | 1,041 | 147,995 | 37,939 | Feb 08, 2024, 07:25 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 06, 2024 | Sale | $142.18 | 3,040 | 432,218 | 504,919 | Feb 08, 2024, 07:21 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Feb 08, 2024 | Sale | $134.15 | 2,274 | 305,052 | 506,962 | Feb 08, 2024, 07:21 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Business Development Off | Feb 06, 2024 | Sale | $142.20 | 1,600 | 227,522 | 133,072 | Feb 08, 2024, 07:17 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Business Development Off | Feb 08, 2024 | Sale | $134.20 | 980 | 131,519 | 133,952 | Feb 08, 2024, 07:17 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Feb 06, 2024 | Sale | $142.12 | 1,280 | 181,910 | 38,751 | Feb 08, 2024, 07:15 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Feb 08, 2024 | Sale | $134.19 | 980 | 131,509 | 39,631 | Feb 08, 2024, 07:15 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 06, 2024 | Sale | $142.19 | 1,280 | 182,000 | 29,434 | Feb 08, 2024, 07:12 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 08, 2024 | Sale | $134.21 | 980 | 131,529 | 30,314 | Feb 08, 2024, 07:12 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Jan 31, 2024 | Sale | $140.79 | 1,457 | 205,132 | 20,832 | Feb 02, 2024, 07:29 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | Chief Scientific Officer | Jan 31, 2024 | Sale | $141.94 | 126 | 17,884 | 11,843 | Feb 02, 2024, 07:26 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | Chief Legal Officer | Jan 31, 2024 | Sale | $140.65 | 1,250 | 175,810 | 37,005 | Feb 02, 2024, 07:24 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 31, 2024 | Sale | $140.69 | 2,707 | 380,845 | 502,188 | Feb 02, 2024, 07:21 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Business Development Off | Jan 31, 2024 | Sale | $140.70 | 1,541 | 216,813 | 131,635 | Feb 02, 2024, 07:17 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Jan 31, 2024 | Sale | $141.94 | 422 | 59,899 | 6,309 | Feb 02, 2024, 07:14 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Feb 01, 2024 | Sale | $139.77 | 623 | 87,077 | 6,865 | Feb 02, 2024, 07:14 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Cooke Julie | Chief Human Resources Officer | Jan 31, 2024 | Sale | $141.29 | 1,740 | 245,842 | 18,087 | Feb 02, 2024, 07:11 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Boyer David W. | Chief Corp. Affairs Officer | Jan 31, 2024 | Sale | $140.80 | 2,096 | 295,115 | 5,886 | Feb 02, 2024, 07:07 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Jan 31, 2024 | Sale | $140.78 | 1,207 | 169,927 | 37,601 | Feb 02, 2024, 07:05 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Jan 31, 2024 | Sale | $140.72 | 1,283 | 180,539 | 28,284 | Feb 02, 2024, 07:00 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | Chief Legal Officer | Jan 22, 2024 | Sale | $139.86 | 10,000 | 1,398,553 | 35,882 | Jan 24, 2024, 05:47 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | Chief Legal Officer | Jan 22, 2024 | Option Exercise | $79.02 | 10,000 | 790,200 | 45,882 | Jan 24, 2024, 05:47 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 08, 2024 | Option Exercise | $19.59 | 105,835 | 2,073,308 | 605,589 | Jan 10, 2024, 04:31 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 08, 2024 | Sale | $132.44 | 105,835 | 14,016,523 | 499,754 | Jan 10, 2024, 04:31 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 09, 2024 | Option Exercise | $19.59 | 62,023 | 1,215,031 | 561,777 | Jan 10, 2024, 04:31 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | Jan 09, 2024 | Sale | $134.01 | 62,023 | 8,311,895 | 499,754 | Jan 10, 2024, 04:31 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Business Development Off | Jan 02, 2024 | Sale | $131.47 | 75,000 | 9,860,195 | 130,250 | Jan 04, 2024, 06:32 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Business Development Off | Jan 02, 2024 | Option Exercise | $19.59 | 75,000 | 1,469,250 | 199,134 | Jan 04, 2024, 06:32 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | Jan 02, 2024 | Option Exercise | $12.98 | 20,000 | 259,600 | 62,785 | Jan 04, 2024, 06:26 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | Jan 02, 2024 | Sale | $131.47 | 11,044 | 1,451,927 | 51,741 | Jan 04, 2024, 06:26 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Dec 22, 2023 | Sale | $126.74 | 10,000 | 1,267,448 | 19,521 | Dec 27, 2023, 04:15 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | Dec 22, 2023 | Sale | $130.04 | 10,000 | 1,300,443 | 193,697 | Dec 27, 2023, 04:10 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Cooke Julie | Chief Human Resources Officer | Dec 22, 2023 | Option Exercise | $73.04 | 24,000 | 1,752,900 | 31,263 | Dec 27, 2023, 04:08 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Cooke Julie | Chief Human Resources Officer | Dec 22, 2023 | Sale | $128.66 | 24,000 | 3,087,808 | 17,263 | Dec 27, 2023, 04:08 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Dec 12, 2023 | Option Exercise | $81.05 | 13,925 | 1,128,621 | 36,499 | Dec 14, 2023, 05:22 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Dec 12, 2023 | Sale | $120.30 | 13,925 | 1,675,240 | 29,521 | Dec 14, 2023, 05:22 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Dec 08, 2023 | Sale | $120.10 | 300 | 36,031 | 29,521 | Dec 11, 2023, 06:18 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Dec 07, 2023 | Option Exercise | $78.52 | 77,379 | 6,076,120 | 68,243 | Dec 11, 2023, 06:18 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Dec 07, 2023 | Sale | $120.37 | 77,379 | 9,314,319 | 29,521 | Dec 11, 2023, 06:18 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Dec 08, 2023 | Option Exercise | $81.05 | 300 | 24,315 | 29,721 | Dec 11, 2023, 06:18 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Dec 06, 2023 | Option Exercise | $77.81 | 8,396 | 653,293 | 37,917 | Dec 08, 2023, 07:09 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | Dec 06, 2023 | Sale | $120.03 | 8,396 | 1,007,780 | 29,521 | Dec 08, 2023, 07:09 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | Chief Legal Officer | Dec 06, 2023 | Option Exercise | $43.24 | 20,830 | 900,689 | 56,712 | Dec 08, 2023, 06:23 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | Chief Legal Officer | Dec 06, 2023 | Sale | $119.86 | 20,830 | 2,496,648 | 35,882 | Dec 08, 2023, 06:23 PM |
Menu